Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 17Colorectal Neoplasms 16Rectal Neoplasms 11Colonic Neoplasms 8Stomach Neoplasms 6Urinary Bladder Neoplasms 5Ovarian Neoplasms 4Neoplasm Metastasis 4Anus Neoplasms 4Adenocarcinoma Of Esophagus 4Squamous Cell Carcinoma of Head and Neck 3Pancreatic Adenocarcinoma 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Esophageal Neoplasms 3Clinical Stage I Gastric Cancer AJCC v8 3Oropharyngeal Neoplasms 2Lung Neoplasms 2Klatskin Tumor 2Fallopian Tube Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Borderline Resectable Pancreatic Adenocarcinoma 2Bile Duct Neoplasms 2Appendiceal Neoplasms 2Anal Canal Carcinoma 2Uterine Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1

Interventions

Gemcitabine 40Cisplatin 24Capecitabine 21Fluorouracil 19Oxaliplatin 17Leucovorin 14pembrolizumab 9Irinotecan 8Radiotherapy 7Erlotinib Hydrochloride 7durvalumab 6Sorafenib 4Magnetic Resonance Spectroscopy 4Carboplatin 4trametinib 3Trastuzumab 3Photochemotherapy 3Long-Term Synaptic Depression 3Interleukin-12 Subunit p35 3Filgrastim 3Dihematoporphyrin Ether 3Dexamethasone 3Chemotherapy, Adjuvant 3trifluridine tipiracil drug combination 2tivozanib 2tislelizumab 2spartalizumab 2regorafenib 2olaparib 2dehydroftorafur 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Bile Duct Neoplasms × dehydroftorafur × Clear all
NCT04164069 2024-12-27

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
9 enrolled
Gastrointestinal

Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02042443 2017-09-12

S1310

National Cancer Institute (NCI)

Phase 2 Completed
53 enrolled 13 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡